Explore the Binding of Hepatitis B Virus Core Protein Peptides with HLA-A2.1 by Molecular Modeling Methods

被引:1
|
作者
Piao, Lianhua [1 ]
Chen, Zhou [2 ]
Chang, Shan [1 ]
Li, Jian [3 ]
Kong, Ren [1 ]
机构
[1] Jiangsu Univ Technol, Sch Elect & Informat Engn, Inst Bioinformat & Med Engn, Changzhou, Peoples R China
[2] Jiangsu Univ Technol, Sch Chem & Environm Engn, Changzhou, Peoples R China
[3] Southeast Univ, Inst Life Sci, Key Lab Dev Genes & Human Dis, Nanjing, Jiangsu, Peoples R China
关键词
D O I
10.1016/j.bpj.2018.11.1026
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
914-Pos
引用
收藏
页码:185A / 185A
页数:1
相关论文
共 50 条
  • [1] Selection of peptides that bind to the HLA-A2.1 molecule by molecular modelling
    Lim, JS
    Kim, S
    Lee, HG
    Lee, KY
    Kwon, TJ
    Kim, K
    [J]. MOLECULAR IMMUNOLOGY, 1996, 33 (02) : 221 - 230
  • [2] HLA-B37 AND HLA-A2.1 MOLECULES BIND LARGELY NONOVERLAPPING SETS OF PEPTIDES
    CARRENO, BM
    ANDERSON, RW
    COLIGAN, JE
    BIDDISON, WE
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (09) : 3420 - 3424
  • [3] Candidate cancer vaccines: Oncogenic mutations in RAS create HLA-A2.1 binding peptides
    Smith, MC
    Pendleton, CD
    Kelley, MJ
    Carbone, DP
    Berzofsky, JA
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 1996, 44 (03) : A247 - A247
  • [4] Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions
    Sarobe, P
    Pendleton, CD
    Akatsuka, T
    Lau, D
    Engelhard, VH
    Feinstone, SM
    Berzofsky, JA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (06): : 1239 - 1248
  • [5] Oncogenic mutations in ras create HLA-A2.1 binding peptides but affect their extracellular antigen processing
    Smith, MC
    Pendleton, CD
    Maher, VE
    Kelley, MJ
    Carbone, DP
    Berzofsky, JA
    [J]. INTERNATIONAL IMMUNOLOGY, 1997, 9 (08) : 1085 - 1093
  • [6] Stability and molecular modeling of triplex DNA inhibiting DNA binding protein binding to the core promoter of hepatitis B virus.
    Yang, J
    Liu, CQ
    [J]. PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2000, 27 (03) : 283 - 286
  • [7] PATIENTS WITH CHRONIC HEPATITIS-C HAVE CIRCULATING CYTOTOXIC T-CELLS WHICH RECOGNIZE HEPATITIS-C VIRUS-ENCODED PEPTIDES BINDING TO HLA-A2.1 MOLECULES
    BATTEGAY, M
    FIKES, J
    DIBISCEGLIE, AM
    WENTWORTH, PA
    SETTE, A
    CELIS, E
    CHING, WM
    GRAKOUL, A
    RICE, CM
    KUROKOHCHI, K
    BERZOFSKY, JA
    HOOFNAGLE, JH
    FEINSTONE, SM
    AKATSUKA, T
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (04) : 2462 - 2470
  • [8] CTL RESPONSES OF HLA-A2.1-TRANSGENIC MICE SPECIFIC FOR HEPATITIS-C VIRAL PEPTIDES PREDICT EPITOPES FOR CTL OF HUMANS CARRYING HLA-A2.1
    SHIRAI, M
    ARICHI, T
    NISHIOKA, M
    NOMURA, T
    IKEDA, K
    KAWANISHI, K
    ENGELHARD, VH
    FEINSTONE, SM
    BERZOFSKY, JA
    [J]. JOURNAL OF IMMUNOLOGY, 1995, 154 (06): : 2733 - 2742
  • [9] SOLUBLE HLA-A2.1 RESTRICTED PEPTIDES THAT ARE RECOGNIZED BY INFLUENZA-VIRUS SPECIFIC CYTOTOXIC LYMPHOCYTES-T
    BEDNAREK, MA
    ENGL, SA
    GAMMON, MC
    LINDQUIST, JA
    PORTER, G
    WILLIAMSON, AR
    ZWEERINK, HJ
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1991, 139 (01) : 41 - 47
  • [10] Molecular characterization of suppression of hepatitis B virus transcription by hepatitis C virus core protein
    Wang, HL
    Yan, ZY
    Hou, YD
    Jin, DY
    [J]. SCIENCE IN CHINA SERIES C-LIFE SCIENCES, 1997, 40 (06): : 648 - 656